Bavarian Nordic — August 2021
-
Det må være ekstremt positivt for BAVA, hvis og når vaccinen godkendes https://ekstrabladet.dk/nyheder/samfund/nyt-studie-immuniteten-falder-efter-seks-maaneder/8790837
-
Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phase 3b Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome
Company announcement – No. 52 / 2021 Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phase 3b Trial Assessing Glepaglutide in Patients with...
GlobeNewswire News Room (www.globenewswire.com)
-
Smitten er steget voldsomt i Israel siden begyndelsen af august, skriver Børsen. Virkning af vaccine falder kraftigt. https://borsen.dk/nyheder/generelt/israel-har-ramt-coronamuren-vaccinen-mister-sin-kraft1. Det viser der er klart er behov for ny vaccine med boostereffekt
-
Johnlau - en fordobling af ExpreS2ion vil komme langt før godkendelse, hvis det ellers når så langt. Kommer de i mål, taler vi om helt andre procenter, og langt mere end en fordobling. Men først er der et par hurdler at passere, OG husk det er risky!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind